2030 年食物過敏治療市場預測：按過敏原類型、藥物類型、給藥途徑、最終用戶和地區進行的全球分析

根據 Stratistics MRC 的數據，2024 年全球食物過敏治療市場價值將達到 71.3 億美元，預計在預測期內複合年成長率為 10.27%，到 2030 年將達到 128.1 億美元。

食物過敏治療主要著重於控制症狀和預防嚴重反應。最好的策略是避免觸發食物，但這很困難，因為過敏原存在於多種食物中。腎上腺素注射對於治療過敏反應（一種可能致命的過敏反應）至關重要，但抗組織胺藥物和皮質類固醇等藥物可用於緩解輕微症狀。免疫療法是治療食物過敏的另一個最新進展，患者隨著時間的推移會接觸少量過敏原並產生耐受性。

根據世界過敏組織 (WAO) 的數據，食物過敏影響全球約 2.2 億至 2.5 億人，其中 5 歲以下兒童的盛行率最高。

食物過敏的盛行率增加

食物過敏在世界各地變得越來越普遍，特別是在北美和歐洲等已開發地區。研究表明，兒童患有食物過敏的比例相當高，估計高達8%。由於多種因素，包括遺傳、飲食變化、加工食品接觸增加以及某些環境因素接觸減少（衛生假說），食物過敏診斷數量不斷增加。此外，病例數的增加增加了對有效治療方法來控制症狀和改善患者生活品質的需求。

昂貴的先進醫療服務

儘管免疫療法和生物製藥等有效的先進治療方法通常需要長期給藥和密切的醫療管理，從而導致高昂的醫療保健成本，這是治療市場面臨的主要挑戰之一。免疫療法可能需要數月或數年才能生效，而單株抗體等生技藥品的製造和使用通常價格昂貴。此外，費用對許多患者來說可能是一個障礙，特別是那些低收入地區和沒有足夠醫療保險覆蓋的患者，限制了獲得先進治療方法的機會並阻礙了他們的接受。

開發客製化治療方法

食物過敏治療擴大透過個人化醫療來進行。基因測試是更先進的診斷工具之一，使醫療保健相關人員能夠根據每位患者的獨特過敏情況制定量身定做的治療方案。生物製藥和免疫療法是兩個受益於此策略的治療方法例子。個人化食物過敏治療對患者來說也是一個有吸引力的選擇，因為它可以採取更強化的方法，副作用更少。此外，對精準醫學和基因組學的日益關注預計將刺激食物過敏治療的進一步進步，並為市場擴張創造新的機會。

與現有治療方法的激烈競爭

目前治療方法的激烈競爭是食物過敏治療市場面臨的主要風險之一。對於食物過敏反應的管理，市面上有許多成熟的治療方法，包括皮質類固醇、腎上腺素注射和抗組織胺。這些治療方法眾所周知且價格實惠，使得免疫療法和生物製藥等更新、更昂貴的治療方法很難獲得市場佔有率。此外，這些眾所周知的治療方法的學名藥的廣泛使用造成了激烈的競爭，並且新產品進入市場的速度很慢，除非它們能提供顯著的優越效果或更便宜。

COVID-19 的影響：

食物過敏治療市場受到了 COVID-19 大流行的顯著影響，無論是積極還是消極。一方面，疫情讓人們更加意識到食物過敏等與健康相關的問題，並學會在不可預測的時期管理自己的整體健康和免疫力。但這場危機也為醫療保健系統帶來了問題，許多患者的常規醫生預約、過敏測試和治療被推遲。臨床試驗和不必要的程序被推遲，影響了新治療方法的開發和可用性。此外，許多患者無法親自接受醫療護理，尤其是在封鎖嚴重的地區，導致診斷和治療的延誤。

預計堅果市場在預測期內將是最大的市場

食物過敏治療市場預計將由樹堅果領域主導。腰果、核桃和杏仁等堅果是最常見的過敏原，因此對有效治療解決方案的需求日益成長。這個細分市場的主導地位得到了人們對樹堅果過敏的廣泛認可，這種過敏可能會導致包括過敏反應在內的嚴重反應。因此，已經開發出腎上腺素注射劑和口服免疫療法等過敏治療方法來抑制和減少過敏反應。此外，該細分市場在更大的食物過敏治療市場中的擴張是由於專門針對樹堅果過敏而設計的醫學研究和治療方法的發展。

免疫治療產業預計在預測期內複合年成長率最高

在食物過敏治療市場中，免疫治療領域預計將以最高的複合年成長率成長。免疫療法能夠逐漸使患者對過敏原脫敏，這使得口服免疫療法（OIT）和舌下免疫療法（SLIT）變得越來越受歡迎。透過培養對食物過敏原的耐受性，這種治療策略可顯著降低嚴重過敏反應的機會。免疫療法（包括針對花生、木本堅果和貝類等常見過敏原）為食物過敏患者提供了長期益處，更多治療方法正在臨床試驗中進行研究並獲得監管機構的核准。

佔比最大的地區：

預計北美地區將佔據食物過敏治療市場的最大佔有率。其主要原因是美國和加拿大等國家，食物過敏的發生率很高，尤其是兒童。其他優點包括該地區對醫學研究和創新的重視、先進的醫療基礎設施以及對食物過敏的普遍認知。由於正在進行的臨床試驗、監管核准以及免疫療法等創新治療方法的開發，北美在食物過敏治療的收益和採用方面處於市場領先地位。此外，該地區的市場主導地位是由腎上腺素注射器和非處方抗組織胺的供應不斷擴大所推動的。

複合年成長率最高的地區：

預計食物過敏治療市場將以亞太地區 (APAC) 最高的複合年成長率成長。在中國、印度、日本和韓國等國家，都市化進程的加速、飲食習慣的改變以及對食物過敏的認知的提高是這一成長的主要驅動力。由於食物過敏被認為是一個嚴重的健康問題，因此越來越需要新的治療方法，例如抗組織胺、腎上腺素注射和免疫療法。此外，由於全部區域醫療保健投資的增加和醫療基礎設施的進步，亞太地區一直是食物過敏治療產業成長率最高的地區。

免費客製化服務：

訂閱此報告的客戶將收到以下免費自訂選項之一：

• 公司簡介
  • 其他市場公司的綜合分析（最多 3 家公司）
  • 主要企業SWOT分析（最多3家企業）
• 區域分割
  • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
• 競爭標基準化分析
  • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

• 概述
• 相關利益者
• 調查範圍
• 調查方法
  • 資料探勘
  • 資料分析
  • 資料檢驗
  • 研究途徑
• 研究資訊來源
  • 主要研究資訊來源
  • 二次研究資訊來源
  • 先決條件

第3章市場趨勢分析

• 促進因素
• 抑制因素
• 機會
• 威脅
• 最終用戶分析
• 新興市場
• COVID-19 的影響

第4章波特五力分析

• 供應商的議價能力
• 買方議價能力
• 替代品的威脅
• 新進入者的威脅
• 競爭公司之間的敵對關係

第5章全球食物過敏治療市場：依過敏原類型

• 乳製品
• 家禽產品
• 堅果
• 花生
• 貝類
• 小麥
• 大豆
• 其他過敏原類型

第6章全球食物過敏治療市場：依藥物類型

• 抗組織胺藥
• 減充血劑
• 皮質類固醇
• 肥大細胞穩定劑
• 白三烯抑制劑
• 鼻用抗膽鹼能藥物
• 免疫調節劑
• 腎上腺素
• 免疫療法
• 其他藥物類型

第7章全球食物過敏治療市場：依給藥途徑

• 口服
• 胃腸外的
• 其他給藥途徑

第8章全球食物過敏治療市場：依最終用戶分類

• 醫院藥房
• 零售藥房
• 其他最終用戶

第9章全球食物過敏治療市場：按地區

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙
  • 其他歐洲國家
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 紐西蘭
  • 韓國
  • 其他亞太地區
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地區
• 中東/非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 卡達
  • 南非
  • 其他中東/非洲

第10章 主要進展

• 合約、夥伴關係、協作和合資企業
• 收購和合併
• 新產品發布
• 業務拓展
• 其他關鍵策略

第11章 公司概況

• Alladapt Immunotherapeutics, Inc.
• F. Hoffman-La Roche Ltd.
• Prota Therapeutics Pty Ltd
• COUR Pharmaceuticals Development Company, Inc
• Novartis Pharmaceuticals
• Teva Pharmaceutical Industries Ltd.
• DBV Technologies
• Stallergenes Greer International AG
• Aravax
• Vedanta Biosciences, Inc.
• Sanofi
• Neogen Corporation
• AstraZeneca
• Mylan NV
• Cambridge Allergy Ltd.

According to Stratistics MRC, the Global Food Allergy Treatment Market is accounted for $7.13 billion in 2024 and is expected to reach $12.81 billion by 2030 growing at a CAGR of 10.27% during the forecast period. Food allergy treatment primarily focuses on managing symptoms and preventing severe reactions. The best strategy is to stay away from trigger foods, but this can be difficult because allergens are present in many different foods. While epinephrine (adrenaline) injections are essential for treating anaphylaxis, a potentially fatal allergic reaction, medications such as antihistamines and corticosteroids may be used to relieve mild symptoms. Immunotherapy is another recent development in the treatment of food allergies, in which patients are exposed to trace amounts of the allergen over time to develop tolerance.

According to the World Allergy Organization (WAO), approximately 220-250 million people globally suffer from food allergies, with the highest prevalence seen in children under the age of 5.

Market Dynamics:

Driver:

Growing food allergy prevalence

Food allergies have been becoming more and more common worldwide, especially in developed areas like North America and Europe. Research shows that a sizable percentage of kids suffer from food allergies; estimates range as high as 8% for this population. The number of food allergy diagnoses is rising due to a number of factors, including genetics, dietary changes, increased exposure to processed foods, and decreased exposure to some environmental factors (hygiene hypothesis). Moreover, the increase in cases is raising the need for efficient therapies that can help patients manage their symptoms and enhance their quality of life.

Restraint:

Expensive advanced medical care

The high cost of advanced therapies, like immunotherapy and biologics, which, although effective, often require long-term administration and close medical supervision, resulting in substantial healthcare costs, is one of the major challenges facing the food allergy treatment market. Immunotherapy treatments can take months or even years to show results, and biologics, such as monoclonal antibodies, are typically expensive to produce and administer. Additionally, the cost can be a barrier for many patients, especially those in low-income regions or those without adequate health insurance coverage, which limits access to advanced therapies and prevents their widespread adoption.

Opportunity:

Development of tailored therapy methods

The treatment of food allergies is increasingly being approached through personalized medicine. Genetic testing is one of the more advanced diagnostic tools that have made it possible for medical professionals to create customized treatment programs that are suited to each patient's unique allergies. Biologics and immunotherapy are two examples of treatments that benefit from this strategy. Personalized food allergy treatments are also a more appealing option for patients because they provide a more focused approach with fewer side effects. Furthermore, the increasing emphasis on precision medicine and genomics is anticipated to spur additional advancements in food allergy therapies, creating new opportunities for market expansion.

Threat:

Intense competition from existing therapies

The fierce competition from current treatments is one of the major risks facing the market for food allergy treatments. For the management of food allergy reactions, the market offers a wide range of well-established treatments, such as corticosteroids, epinephrine injections, and antihistamines. Because these treatments are well-known and reasonably priced, it is difficult for more recent and costly treatments like immunotherapy and biologics to increase their market share. Moreover, the fierce competition created by the widespread availability of generic versions of these well-known medications makes it more difficult for new products to take off unless they provide noticeably better advantages or are more affordable.

Covid-19 Impact:

The market for food allergy treatments was significantly impacted by the COVID-19 pandemic, both positively and negatively. On the one hand, the pandemic raised people's awareness of health-related problems, such as food allergies, as they learned to manage their general well-being and immunity in unpredictable times. But the crisis also caused problems for healthcare systems, causing many patients' regular doctor's appointments, allergy tests, and treatments to be postponed. Clinical trials and non-essential procedures were delayed, which had an impact on the creation and accessibility of novel treatments. Furthermore, a lot of patients had trouble getting in-person consultations, especially in areas with stringent lockdowns, which caused delays in diagnosis and treatment.

The Tree Nuts segment is expected to be the largest during the forecast period

The food allergy treatment market is expected to be largest share by the tree nuts segment. Since tree nuts like cashews, walnuts, and almonds are among the most common allergens, there is a greater need for efficient treatment solutions. The broad awareness of tree nut allergies, which can result in severe reactions, including anaphylaxis, is what propels the segment's dominance. As a result, allergy treatments like epinephrine injections and oral immunotherapy have been developed to control and lessen allergic reactions. Additionally, the expansion of this market segment within the larger food allergy treatment market is being driven by developments in medical research and treatments designed especially to address tree nut allergies.

The Immunotherapy segment is expected to have the highest CAGR during the forecast period

In the food allergy treatment market, the immunotherapy segment is anticipated to grow at the highest CAGR. Because immunotherapy has the ability to gradually desensitize patients to allergens, it is becoming increasingly popular, especially oral immunotherapy (OIT) and sublingual immunotherapy (SLIT). By fostering tolerance to food allergens, this therapeutic strategy considerably lowers the likelihood of severe allergic reactions. Immunotherapy provides long-term benefits for patients with food allergies, including those to common allergens like peanuts, tree nuts, and shellfish, as clinical research continues to advance and more treatments are approved by regulators.

Region with largest share:

The Food Allergy Treatment Market is expected to be the largest share by the North American region. The main cause of this is the high incidence of food allergies, especially in children, in nations like the US and Canada. Additionally, the area benefits from a strong emphasis on medical research and innovation, a sophisticated healthcare infrastructure, and general awareness of food allergies. North America leads the market in terms of revenue and adoption of food allergy treatments due to ongoing clinical trials, regulatory approvals, and the development of innovative treatments like immunotherapy. Moreover, the region's dominant market position is facilitated by the expanding availability of epinephrine injectors and over-the-counter antihistamines.

Region with highest CAGR:

The food allergy treatment market is anticipated to grow at the highest CAGR in the Asia Pacific (APAC) region. In nations like China, India, Japan, and South Korea, growing urbanization, dietary changes, and growing awareness of food allergies are the main causes of this growth. The need for treatments like antihistamines, epinephrine injectors, and newer therapies like immunotherapy is rising as food allergies are acknowledged as a serious health issue. Furthermore, APAC is now the region with the fastest rate of growth in the food allergy treatment industry owing to rising healthcare investments and advancements in medical infrastructure throughout the region.

Key players in the market

Some of the key players in Food Allergy Treatment market include Alladapt Immunotherapeutics, Inc., F. Hoffman-La Roche Ltd., Prota Therapeutics Pty Ltd, COUR Pharmaceuticals Development Company, Inc, Novartis Pharmaceuticals, Teva Pharmaceutical Industries Ltd., DBV Technologies, Stallergenes Greer International AG, Aravax, Vedanta Biosciences, Inc., Sanofi, Neogen Corporation, AstraZeneca, Mylan N.V. and Cambridge Allergy Ltd.

Key Developments:

In December 2024, Teva Pharmaceutical Industries Ltd. announced that it has entered into an agreement with JKI, established by the fund managed and operated by J-Will, whereby all shares of Teva Takeda Pharma Limited and its wholly owned subsidiary Teva Takeda Yakuhin Ltd. will be transferred to JKI.

In September 2024, Sanofi has entered into an exclusive licensing agreement with RadioMedix, Inc., a US clinical-stage biotechnology company developing radiopharmaceuticals for PET imaging and targeted alpha therapy (TAT) against unmet medical needs in cancer, and Orano Med, a French clinical-stage biotechnology company, subsidiary of the Orano Group, developing lead-212 (212Pb) radioligand therapies (RLTs) against cancer.

In February 2024, Novartis announced that it has entered into an agreement to make a voluntary public takeover offer to acquire MorphoSys AG, a Germany-based, global biopharmaceutical company developing innovative medicines in oncology.

Allergen Types Covered:

• Dairy Products
• Poultry Products
• Tree Nuts
• Peanuts
• Shellfish
• Wheat
• Soys
• Other Allergen Types

Drug Types Covered:

• Antihistamines
• Decongestants
• Corticosteroids
• Mast Cell Stabilizers
• Leukotriene Inhibitors
• Nasal Anti-cholinergic
• Immuno-modulators
• Epinephrine
• Immunotherapy
• Other Drug Types

Route of Administrations Covered:

• Oral
• Parenteral
• Other Route of Administrations

End Users Covered:

• Hospital Pharmacies
• Retail Pharmacies
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 End User Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Food Allergy Treatment Market, By Allergen Type

• 5.1 Introduction
• 5.2 Dairy Products
• 5.3 Poultry Products
• 5.4 Tree Nuts
• 5.5 Peanuts
• 5.6 Shellfish
• 5.7 Wheat
• 5.8 Soys
• 5.9 Other Allergen Types

6 Global Food Allergy Treatment Market, By Drug Type

• 6.1 Introduction
• 6.2 Antihistamines
• 6.3 Decongestants
• 6.4 Corticosteroids
• 6.5 Mast Cell Stabilizers
• 6.6 Leukotriene Inhibitors
• 6.7 Nasal Anti-cholinergic
• 6.8 Immuno-modulators
• 6.9 Epinephrine
• 6.10 Immunotherapy
• 6.11 Other Drug Types

7 Global Food Allergy Treatment Market, By Route of Administration

• 7.1 Introduction
• 7.2 Oral
• 7.3 Parenteral
• 7.4 Other Route of Administrations

8 Global Food Allergy Treatment Market, By End User

• 8.1 Introduction
• 8.2 Hospital Pharmacies
• 8.3 Retail Pharmacies
• 8.4 Other End Users

9 Global Food Allergy Treatment Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Alladapt Immunotherapeutics, Inc.
• 11.2 F. Hoffman-La Roche Ltd.
• 11.3 Prota Therapeutics Pty Ltd
• 11.4 COUR Pharmaceuticals Development Company, Inc
• 11.5 Novartis Pharmaceuticals
• 11.6 Teva Pharmaceutical Industries Ltd.
• 11.7 DBV Technologies
• 11.8 Stallergenes Greer International AG
• 11.9 Aravax
• 11.10 Vedanta Biosciences, Inc.
• 11.11 Sanofi
• 11.12 Neogen Corporation
• 11.13 AstraZeneca
• 11.14 Mylan N.V.
• 11.15 Cambridge Allergy Ltd.

List of Tables

• Table 1 Global Food Allergy Treatment Market Outlook, By Region (2022-2030) ($MN)
• Table 2 Global Food Allergy Treatment Market Outlook, By Allergen Type (2022-2030) ($MN)
• Table 3 Global Food Allergy Treatment Market Outlook, By Dairy Products (2022-2030) ($MN)
• Table 4 Global Food Allergy Treatment Market Outlook, By Poultry Products (2022-2030) ($MN)
• Table 5 Global Food Allergy Treatment Market Outlook, By Tree Nuts (2022-2030) ($MN)
• Table 6 Global Food Allergy Treatment Market Outlook, By Peanuts (2022-2030) ($MN)
• Table 7 Global Food Allergy Treatment Market Outlook, By Shellfish (2022-2030) ($MN)
• Table 8 Global Food Allergy Treatment Market Outlook, By Wheat (2022-2030) ($MN)
• Table 9 Global Food Allergy Treatment Market Outlook, By Soys (2022-2030) ($MN)
• Table 10 Global Food Allergy Treatment Market Outlook, By Other Allergen Types (2022-2030) ($MN)
• Table 11 Global Food Allergy Treatment Market Outlook, By Drug Type (2022-2030) ($MN)
• Table 12 Global Food Allergy Treatment Market Outlook, By Antihistamines (2022-2030) ($MN)
• Table 13 Global Food Allergy Treatment Market Outlook, By Decongestants (2022-2030) ($MN)
• Table 14 Global Food Allergy Treatment Market Outlook, By Corticosteroids (2022-2030) ($MN)
• Table 15 Global Food Allergy Treatment Market Outlook, By Mast Cell Stabilizers (2022-2030) ($MN)
• Table 16 Global Food Allergy Treatment Market Outlook, By Leukotriene Inhibitors (2022-2030) ($MN)
• Table 17 Global Food Allergy Treatment Market Outlook, By Nasal Anti-cholinergic (2022-2030) ($MN)
• Table 18 Global Food Allergy Treatment Market Outlook, By Immuno-modulators (2022-2030) ($MN)
• Table 19 Global Food Allergy Treatment Market Outlook, By Epinephrine (2022-2030) ($MN)
• Table 20 Global Food Allergy Treatment Market Outlook, By Immunotherapy (2022-2030) ($MN)
• Table 21 Global Food Allergy Treatment Market Outlook, By Other Drug Types (2022-2030) ($MN)
• Table 22 Global Food Allergy Treatment Market Outlook, By Route of Administration (2022-2030) ($MN)
• Table 23 Global Food Allergy Treatment Market Outlook, By Oral (2022-2030) ($MN)
• Table 24 Global Food Allergy Treatment Market Outlook, By Parenteral (2022-2030) ($MN)
• Table 25 Global Food Allergy Treatment Market Outlook, By Other Route of Administrations (2022-2030) ($MN)
• Table 26 Global Food Allergy Treatment Market Outlook, By End User (2022-2030) ($MN)
• Table 27 Global Food Allergy Treatment Market Outlook, By Hospital Pharmacies (2022-2030) ($MN)
• Table 28 Global Food Allergy Treatment Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
• Table 29 Global Food Allergy Treatment Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.